• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION OXIRIS SET; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION OXIRIS SET; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Catalog Number 955540
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Arrest (1762); Hemolysis (1886)
Event Date 09/21/2022
Event Type  Injury  
Event Description
It was reported that at an unknown time during continuous renal replacement therapy with a prismaflex oxiris set and a prismaflex control unit, reddish effluent was observed.No blood leak detection alarm was generated, and no effluent sampling was reported for confirmation of red blood cells.It was further reported the patient experienced hemolysis and cardiac arrest.It was reported the patient received continuous cardiac compression rescue.At the time of this report the patient outcome was not reported.No additional information is available.
 
Manufacturer Narrative
(b)(6).Oxiris c is similar to oxiris and oxiris s.Oxiris and oxiris s have been temporarily approved for use in the us under emergency use authorization eua200164 with a specific indication to treat patients with covid-19 infection.Should additional relevant information become available, a supplemental report will be submitted.
 
Manufacturer Narrative
Additional information: h3, h6 and h10.H10: the actual sample was not available; however, photos of the sample were provided for evaluation.Visual inspection observed a red coloration in the effluent fluid.The reported condition was verified.The cause could not be determined.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OXIRIS SET
Type of Device
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
Manufacturer (Section G)
BAXTER HEALTHCARE - MEYZIEU
7, av lionel terray, b.p. 126
meyzieu cedex rhone 69883
FR   69883
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 
2242702068
MDR Report Key15663171
MDR Text Key302328892
Report Number8010182-2022-00322
Device Sequence Number1
Product Code KDI
UDI-Device Identifier07332414124090
UDI-Public(01)07332414124090
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Nurse Practitioner
Type of Report Initial,Followup
Report Date 11/22/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/31/2024
Device Catalogue Number955540
Device Lot Number22B0085
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/26/2022
Initial Date FDA Received10/24/2022
Supplement Dates Manufacturer Received10/26/2022
Supplement Dates FDA Received11/22/2022
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
PRISMAFLEX MACHINE
Patient Outcome(s) Required Intervention;
Patient Age81 YR
Patient SexMale
-
-